Biolabssss

During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.

Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and micr

Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and micr

In recent years, low-cost nucleic acid solutions on microfluidic chips have been developed, which would become a more valuable platform and one of the most common tools in the biomedical field. Creative Biolabs is a leader in microfluidic chip development. With years of experience and advanced microfluidic platforms, our scientists are pleased to offer the best-qualified outcomes to meet our customers' specific requirements for the development of microfluidic chips.

The currently used 2D monolayer cells cannot accurately reflect the structure, function, and mechanical characteristics of living tissue, nor can they reproduce the highly complex and dynamic 3D environment in the body. The organo-on-a-chip based on microfluidic technology can simulate the complex structure, microenvironment and physiological functions of human organs, so it has gradually become an ideal tool for new drug screening and toxicity evaluation. Creative Biolabs can provide customers with high-quality organ-on-a-chip design and customization services relying on its profound technic

Creative Biolabs is a leading global biologics company established in the United States. With more than a decade of exploration and expansion, Creative Biolabs offers comprehensive one-stop services for Complement Therapeutics. Our project procedure can be totally designed to meet your special requirements. We will be your best partner in Complement-based Drug Discovery.

Creative Biolabs is a leading global biologics company established in the United States. With more than a decade of exploration and expansion, Creative Biolabs offers comprehensive one-stop services for Complement Therapeutics. Our project procedure can be totally designed to meet your special requirements. We will be your best partner in Complement-based Drug Discovery.

As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins.

As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins.

Creative Biolabs possesses unchallenged experience in synthesis of tetravalent heavy chain-only antibodies (hcAbs). Multiple platforms of Creative Biolabs are elaborately integrated for providing customer an expected tetravalent hcAb with high affinity and low immunogenicity for both academic and clinical purposes.

Creative Biolabs offers clients design and construction services of a novel form bispecific antibodies (BsAbs), the KIH IgG-scFab, for many different studies about antibody engineering. We are confident to deliver you a BsAb that can meet all of your required specifications.

Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies.

Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide. In the past decade, we have become a leader in discovering and manufacturing recombinant antibodies.

The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.

The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.